LABIANA HEALTH S.A.EO-10 Capital Reinvestment Ratio

Latest as of December 2025: 2.61x

LABIANA HEALTH S.A.EO-10 capital reinvestment ratio. LABIANA HEALTH S.A.EO-10 (8RK) has a Capital Reinvestment Ratio of 2.61x as of December 2025, meaning it reinvests 3% of its operating cash flow (€1.70 Million) in capital expenditures (€4.44 Million). See how much free cash does LABIANA HEALTH S.A.EO-10 generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.61x
Capex / Operating Cash Flow

Operating Cash Flow

€1.70 Million
EUR

Capital Expenditures

€4.44 Million
EUR

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of LABIANA HEALTH S.A.EO-10 (2021–2025)

Capital reinvestment ratio of LABIANA HEALTH S.A.EO-10 from 2021 to 2025. This chart tracks LABIANA HEALTH S.A.EO-10's Capital Reinvestment Ratio across 4 annual periods. See financial flexibility index of LABIANA HEALTH S.A.EO-10 to measure the company's free cash flow as a share of total liabilities.

LABIANA HEALTH S.A.EO-10 Capital Reinvestment Ratio by Year (2021–2025)

LABIANA HEALTH S.A.EO-10 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of LABIANA HEALTH S.A.EO-10.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 2.61x €1.70 Million €4.44 Million ▲ +516.3%
2024 0.42x €7.19 Million €3.05 Million ▼ -63.7%
2022 1.17x €4.68 Million €5.45 Million ▼ -4.5%
2021 1.22x €3.91 Million €4.77 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow